CureMatch Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 26

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 9

CureMatch General Information

Description

Developer of a decision support software designed to transform cancer treatment with precision medicine. The company's software analyzes genetic information and compares it with a database of information from medical experts, other patients, clinical trials, and published data to save lives and improve medical outcomes, enabling oncologists to provide customized drugs for individual patients based on their molecular tumor profile.

Contact Information

Website
www.curematch.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 9920 Pacific Heights Boulevard
  • Suite 150
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Decision/Risk Analysis
Other Industries
Biotechnology
Outcome Management (Healthcare)
Vertical(s)
Digital Health, Life Sciences, Oncology
Corporate Office
  • 9920 Pacific Heights Boulevard
  • Suite 150
  • San Diego, CA 92121
  • United States
+1 (858)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CureMatch Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 01-Jun-2021 Completed Generating Revenue
7. Secondary Transaction - Private Completed Generating Revenue
6. Early Stage VC Completed Generating Revenue
5. Early Stage VC (Series A) 17-Jul-2018 Completed Generating Revenue
4. Grant 07-Jun-2018 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2017 Completed Generating Revenue
2. Seed Round 01-Jan-2016 Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2016 Completed Generating Revenue
To view CureMatch’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

CureMatch Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a decision support software designed to transform cancer treatment with precision medicine. The company's s
Decision/Risk Analysis
San Diego, CA
26 As of 2025

Cleveland, OH
 

Atlanta, GA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CureMatch Competitors (3)

One of CureMatch’s 3 competitors is GenomOncology, a Venture Capital-Backed company based in Cleveland, OH.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GenomOncology Venture Capital-Backed Cleveland, OH
OncoHealth (Atlanta) Private Equity-Backed Atlanta, GA
Flatiron Formerly VC-backed New York, NY
You’re viewing 3 of 3 competitors. Get the full list »

CureMatch Patents

  • 15

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

CureMatch Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250006317-A1 Clinical trial optimization Pending 23-Nov-2021
CA-3076918-A1 Method of prediction of tumor-derived neo-peptide antigenicity and/or immunogenicity using mutational signature patterns Inactive 02-Oct-2017
EP-3691676-A1 Method of prediction of tumor-derived neo-peptide antigenicity and/or immunogenicity using mutational signature patterns Inactive 02-Oct-2017
EP-3691676-A4 Method of prediction of tumor-derived neo-peptide antigenicity and/or immunogenicity using mutational signature patterns Inactive 02-Oct-2017
US-20200362418-A1 Method of prediction of tumor-derived neo-peptide antigenicity and/or immunogenicity using mutational signature patterns Inactive 02-Oct-2017 C12Q1/6886
To view CureMatch’s complete patent history, request access »

CureMatch Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CureMatch Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
UnitLeader Venture Capital Minority
Angel (individual) Minority
MetroConnect Accelerator Accelerator/Incubator Minority
Analytics Ventures Accelerator/Incubator Minority
CONNECT(San Diego) Accelerator/Incubator
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

CureMatch FAQs

  • When was CureMatch founded?

    CureMatch was founded in 2015.

  • Where is CureMatch headquartered?

    CureMatch is headquartered in San Diego, CA.

  • What is the size of CureMatch?

    CureMatch has 26 total employees.

  • What industry is CureMatch in?

    CureMatch’s primary industry is Decision/Risk Analysis.

  • Is CureMatch a private or public company?

    CureMatch is a Private company.

  • What is CureMatch’s current revenue?

    The current revenue for CureMatch is .

  • How much funding has CureMatch raised over time?

    CureMatch has raised $2.31M.

  • Who are CureMatch’s investors?

    UnitLeader, , MetroConnect Accelerator, Analytics Ventures, and CONNECT(San Diego) are 5 of 9 investors who have invested in CureMatch.

  • Who are CureMatch’s competitors?

    GenomOncology, OncoHealth (Atlanta), and Flatiron are competitors of CureMatch.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »